New cell therapy trial offers hope for leukemia patients who Can't handle chemo
NCT ID NCT07335094
Summary
This early-stage study is testing the safety and initial effectiveness of a modified CAR-T cell therapy for adults with a type of blood cancer called B-cell acute lymphoblastic leukemia/lymphoma. It is specifically for patients who are newly diagnosed but cannot tolerate the intense chemotherapy that is usually given first. Participants will receive a single infusion of these engineered immune cells and be followed for three years.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for B LYMPHOBLASTIC LEUKEMIA/LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.